Castle Biosciences Stock (NASDAQ: CSTL) stock price, news, charts, stock research, profile.
Open | $24.510 |
Close | $24.240 |
Volume / Avg. | 357.764K / 253.695K |
Day Range | 23.910 - 24.815 |
52 Wk Range | 9.260 - 26.700 |
Market Cap | $669.198M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 5.45% |
Days to Cover | 10.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Castle Biosciences (NASDAQ: CSTL) through any online brokerage.
Other companies in Castle Biosciences’s space includes: GeneDx Hldgs (NASDAQ:WGS), Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Castle Biosciences (NASDAQ: CSTL) was reported by Baird on Friday, May 3, 2024. The analyst firm set a price target for 34.00 expecting CSTL to rise to within 12 months (a possible 40.26% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Castle Biosciences (NASDAQ: CSTL) is $24.24 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Castle Biosciences.
Castle Biosciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Castle Biosciences.
Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.